Start-up
Globavir, Inc.
Treating Global Infectious Diseases
About Globavir
Globavir strives to develop medicines that will revolutionize the treatment of infectious diseases
Globavir's Infectious Disease pipeline includes GBV006, a broad spectrum antiviral being evaluated for the treatment of Chikungunya and Dengue infections
Globavir also offers best-in-class Dengue Diagnostic tests
Facts about Globavir
Facts about Globavir
- Founding: 2011
- Focus : Service
- Employees: 11-50
- Industry : Pharma